Norway· NO-ID_A3E05C1D-790A-4257-915F-7FC1367D6D66
Carboplatin Fresenius Kabi
A carboplatin product containing carboplatin, registered in Norway by Fresenius Kabi Norge AS. The same ATC class is registered in 17 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Carboplatin is registered in 17 of 19 countries.
Countries holding a registration under ATC L01XA02 (carboplatin), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Carboplatin · ATC L01XA02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of carboplatin costs, country by country.
Normalised to the WHO defined daily dose (25 mg), the median price runs from $0.34 in Czechia to $7.73 in Switzerland — a ×23 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Carboplatin · price per daily dose (25 mg)
USD · FX 28 Sept 2026
- CH Switzerland$7.73
- CZ Czechia$0.34
The record
At a glance
FEST (Norway)- Active substance
- Carboplatin
- Manufacturer
- Fresenius Kabi Norge AS
- Country
- Norway (NO)
- ATC code
- L01XA02
- ATC class
- Carboplatin
- Defined daily dose
- 25 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 9
4 priced- gtin4052682019913
- gtin4052682019814
- gtin4052682019821
- gtin4052682019920
- no_merkevare_idID_A3E05C1D-790A-4257-915F-7FC1367D6D66
- no_varenummer4278011 x 5NOK 343.4
- no_varenummer1799421 x 15NOK 957.8
- no_varenummer3742131 x 45NOK 2800.9
- no_varenummer5076621 x 60NOK 3722.5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
564 interactions on record for carboplatin.
Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Carboplatin · interactions on record
564 records
- 37 severe
- 205 moderate
- 15 minor
- 307 info
Most severe, free to view
- CidofovirJ05AB12severe
- ThiotepaL01AC01severe
- CladribineL01BB04severe
- TopotecanL01CE01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Carboplatin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCarboplatin Accord Healthcare 10 mg/mlAccord Healthcare
- FinlandCarboloxJacobsen Pharma AS
- CzechiaCARBOPLATIN ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- SwedenCarbomedac 10 mg/ml Koncentrat till infusionsvätska, lösningmedac Gesellschaft für klinische Spezialpräparate mbH
- PolandCarbomedacmedac Gesellschaft fur klinische Specialpraparate mbH
- IrelandCarboplatin 10 mg/ml concentrate for solution for infusionAccord Healthcare Ireland Ltd.
- IcelandCarboplatin ActavisActavis Group PTC ehf.
- United KingdomCarboplatin 1000mg/500ml in Glucose 5% infusion bagsSpecial Order
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Carboplatin Accord, Carboplatin Ebewe
- Belgium · Carboplatin Accord Healthcare, Carboplatin Eugia
- Bulgaria · Карбоплатин Ебеве
- Cyprus · Carboplatin Accord, Carboplatin Accord Healthcare
- Czechia · Carboplatin Accord, Carboplatin Kabi
- Germany · Carbo-Cell, Carbo-Cell®
- Denmark · Carbomedac, Carboplatin "ebewe"
- Estonia · Carboplatin Accord, Carboplatin Kabi
- Spain · Carboplatino Accord, Carboplatino Aurovitas
- Finland · Carboplatin Accord, Carboplatin Ebewe
- France · Carboplatine Accord, Carboplatine Arrow Lab
- United Kingdom (Northern Ireland) · Carboplatin Accord Healthcare, Carboplatin Amarox
- Greece · Carboplan, Carboplatin Hospira
- Croatia · Karboplatin Accord, Karboplatin Pontus
- Hungary · Carboplatin Accord, Carboplatin Kabi
- Ireland · Carboplatin, Carboplatin Accord Healthcare Ireland
- Iceland · Carboplatin Actavis, Carboplatin Fresenius Kabi
- Italy · Carboplatino Ahcl, Carboplatino Aurobindo Italia
- Lithuania · Carboplatin Accord, Carboplatin Kabi
- Luxembourg · Carboplatine Fresenius Kabi, Carboplatine Onco-Tain Hospira
- Latvia · Carboplatin Accord, Carboplatin Ebewe
- Malta · Carboplan, Carboplatin Accord Healthcare
- Netherlands · Carboplatin Accord, Carboplatine Fresenius Kabi
- Poland · Carbomedac, Carboplatin Accord
- Portugal · Carboplatina Accord, Carboplatina Generis
- Romania · Carboplatin Actavis, Carboplatin Kabi
- Sweden · Carbomedac, Carboplatin Accord
- Slovenia · Carboplatin Ebewe, Karboplatin Accord
- Slovakia · Carbomedac, Carboplatin Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/329d98ca-e770-4db3-ac86-a9fc89ec9b08 GET /v1/drugs/329d98ca-e770-4db3-ac86-a9fc89ec9b08?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Karboplatin",
"merkevare_id": "ID_A3E05C1D-790A-4257-915F-7FC1367D6D66",
"name_form_strength": "Carboplatin Fresenius Kabi kons til inf oppl 10 mg/ml",
"prescription_group": "C"
}See everything about carboplatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.